Inovio Pharmaceuticals Faces Class Action Over Device Manufacturing Disclosures
Inovio Pharmaceuticals faces class action lawsuit for allegedly misleading investors about device manufacturing capabilities and regulatory delays, leading to 24% stock decline.
INOsecurities fraudclass action lawsuit
